Palmitoleic acid reduces intramuscular lipid and restores insulin sensitivity in obese sheep

Susan K Duckett, Gabriela Volpi-Lagreca, Mariano Alende, Nathan M LongAnimal and Veterinary Sciences Department, Clemson University, Clemson, SC, USAAbstract: Obese sheep were used to assess the effects of palmitoleic (C16:1 cis-9) acid infusion on lipogenesis and circulating insulin levels. Infusio...

Full description

Bibliographic Details
Main Authors: Duckett SK, Volpi-Lagreca G, Alende M, Long NM
Format: Article
Language:English
Published: Dove Medical Press 2014-11-01
Series:Diabetes, Metabolic Syndrome and Obesity
Online Access:http://www.dovepress.com/palmitoleic-acid-reduces-intramuscular-lipid-and-restores-insulin-sens-peer-reviewed-article-DMSO
_version_ 1797700075715035136
author Duckett SK
Volpi-Lagreca G
Alende M
Long NM
author_facet Duckett SK
Volpi-Lagreca G
Alende M
Long NM
author_sort Duckett SK
collection DOAJ
description Susan K Duckett, Gabriela Volpi-Lagreca, Mariano Alende, Nathan M LongAnimal and Veterinary Sciences Department, Clemson University, Clemson, SC, USAAbstract: Obese sheep were used to assess the effects of palmitoleic (C16:1 cis-9) acid infusion on lipogenesis and circulating insulin levels. Infusion of 10 mg/kg body weight (BW)/day C16:1 intravenously in obese sheep reduced (P<0.01) weight gain by 77%. Serum palmitoleic levels increased (P<0.05) in a linear manner with increasing levels of C16:1 infusion. Cis-11 vaccenic (C18:1 cis-11) acid, a known elongation product of palmitoleic acid, was also elevated (P<0.05) in serum after 14 days and 21 days of infusion. Plasma insulin levels were lower (P<0.05) (10 mg/kg BW/day C16:1) than controls (0 mg/kg BW/day C16:1) at 14 days and 28 days of infusion. Infusion of C16:1 resulted in linear increases in tissue concentrations of palmitoleic, cis-11 vaccenic, eicosapentaenoic, and docosapentaenoic acids in a dose-dependent manner. Total lipid content of the semitendinosus (ST) muscle and mesenteric adipose tissue was reduced (P<0.01) in both 5 mg/kg and 10 mg/kg BW C16:1 dose levels. Total lipid content and mean adipocyte size in the longissimus muscle was reduced (P<0.05) in the 10 mg/kg BW C16:1 dose level only, whereas total lipid content and adipocyte size of the subcutaneous adipose tissue was not altered. Total lipid content of the liver was also unchanged with C16:1 infusion. Palmitoleic acid infusion upregulated (P<0.05) acetyl-CoA carboxylase (ACC), fatty acid elongase-6 (ELOVL6), and Protein kinase, AMP-activated, alpha 1 catalytic subunit, transcript variant 1 (AMPK) mRNA expressions in liver, subcutaneous adipose, and ST muscle compared to the controls. However, mRNA expression of glucose transporter type 4 (GLUT4) and carnitine palmitoyltransferase 1b (CPT1B) differed between tissues. In the subcutaneous adipose and liver, C16:1 infusion upregulated (P<0.05) GLUT4 and CPT1B, whereas these genes were downregulated (P<0.05) in ST muscle with C16:1 infusion. These results show that C16:1 infusion for 28 days reduced weight gain, intramuscular adipocyte size and total lipid content, and circulating insulin levels. These changes appear to be mediated through alterations in expression of genes regulating glucose uptake and fatty acid oxidation specifically in the muscles.Keywords: adipocytes, longissimus muscle, lipogenesis, insulin level, serum, fatty acid
first_indexed 2024-03-12T04:16:46Z
format Article
id doaj.art-2515b9d10037499d8c3fc427651cd61e
institution Directory Open Access Journal
issn 1178-7007
language English
last_indexed 2024-03-12T04:16:46Z
publishDate 2014-11-01
publisher Dove Medical Press
record_format Article
series Diabetes, Metabolic Syndrome and Obesity
spelling doaj.art-2515b9d10037499d8c3fc427651cd61e2023-09-03T10:34:59ZengDove Medical PressDiabetes, Metabolic Syndrome and Obesity1178-70072014-11-012014default55356319231Palmitoleic acid reduces intramuscular lipid and restores insulin sensitivity in obese sheepDuckett SKVolpi-Lagreca GAlende MLong NMSusan K Duckett, Gabriela Volpi-Lagreca, Mariano Alende, Nathan M LongAnimal and Veterinary Sciences Department, Clemson University, Clemson, SC, USAAbstract: Obese sheep were used to assess the effects of palmitoleic (C16:1 cis-9) acid infusion on lipogenesis and circulating insulin levels. Infusion of 10 mg/kg body weight (BW)/day C16:1 intravenously in obese sheep reduced (P<0.01) weight gain by 77%. Serum palmitoleic levels increased (P<0.05) in a linear manner with increasing levels of C16:1 infusion. Cis-11 vaccenic (C18:1 cis-11) acid, a known elongation product of palmitoleic acid, was also elevated (P<0.05) in serum after 14 days and 21 days of infusion. Plasma insulin levels were lower (P<0.05) (10 mg/kg BW/day C16:1) than controls (0 mg/kg BW/day C16:1) at 14 days and 28 days of infusion. Infusion of C16:1 resulted in linear increases in tissue concentrations of palmitoleic, cis-11 vaccenic, eicosapentaenoic, and docosapentaenoic acids in a dose-dependent manner. Total lipid content of the semitendinosus (ST) muscle and mesenteric adipose tissue was reduced (P<0.01) in both 5 mg/kg and 10 mg/kg BW C16:1 dose levels. Total lipid content and mean adipocyte size in the longissimus muscle was reduced (P<0.05) in the 10 mg/kg BW C16:1 dose level only, whereas total lipid content and adipocyte size of the subcutaneous adipose tissue was not altered. Total lipid content of the liver was also unchanged with C16:1 infusion. Palmitoleic acid infusion upregulated (P<0.05) acetyl-CoA carboxylase (ACC), fatty acid elongase-6 (ELOVL6), and Protein kinase, AMP-activated, alpha 1 catalytic subunit, transcript variant 1 (AMPK) mRNA expressions in liver, subcutaneous adipose, and ST muscle compared to the controls. However, mRNA expression of glucose transporter type 4 (GLUT4) and carnitine palmitoyltransferase 1b (CPT1B) differed between tissues. In the subcutaneous adipose and liver, C16:1 infusion upregulated (P<0.05) GLUT4 and CPT1B, whereas these genes were downregulated (P<0.05) in ST muscle with C16:1 infusion. These results show that C16:1 infusion for 28 days reduced weight gain, intramuscular adipocyte size and total lipid content, and circulating insulin levels. These changes appear to be mediated through alterations in expression of genes regulating glucose uptake and fatty acid oxidation specifically in the muscles.Keywords: adipocytes, longissimus muscle, lipogenesis, insulin level, serum, fatty acidhttp://www.dovepress.com/palmitoleic-acid-reduces-intramuscular-lipid-and-restores-insulin-sens-peer-reviewed-article-DMSO
spellingShingle Duckett SK
Volpi-Lagreca G
Alende M
Long NM
Palmitoleic acid reduces intramuscular lipid and restores insulin sensitivity in obese sheep
Diabetes, Metabolic Syndrome and Obesity
title Palmitoleic acid reduces intramuscular lipid and restores insulin sensitivity in obese sheep
title_full Palmitoleic acid reduces intramuscular lipid and restores insulin sensitivity in obese sheep
title_fullStr Palmitoleic acid reduces intramuscular lipid and restores insulin sensitivity in obese sheep
title_full_unstemmed Palmitoleic acid reduces intramuscular lipid and restores insulin sensitivity in obese sheep
title_short Palmitoleic acid reduces intramuscular lipid and restores insulin sensitivity in obese sheep
title_sort palmitoleic acid reduces intramuscular lipid and restores insulin sensitivity in obese sheep
url http://www.dovepress.com/palmitoleic-acid-reduces-intramuscular-lipid-and-restores-insulin-sens-peer-reviewed-article-DMSO
work_keys_str_mv AT duckettsk palmitoleicacidreducesintramuscularlipidandrestoresinsulinsensitivityinobesesheep
AT volpilagrecag palmitoleicacidreducesintramuscularlipidandrestoresinsulinsensitivityinobesesheep
AT alendem palmitoleicacidreducesintramuscularlipidandrestoresinsulinsensitivityinobesesheep
AT longnm palmitoleicacidreducesintramuscularlipidandrestoresinsulinsensitivityinobesesheep